Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CONDENSED CYCLIC COMPOUND HAVING DOPAMINE D3 RECEPTOR ANTAGONISM
Document Type and Number:
WIPO Patent Application WO/2019/146739
Kind Code:
A1
Abstract:
Provided is a novel compound which has D3 receptor antagonism. A compound represented by formula (IA)' (wherein: A represents S or O; R1a represents optionally substituted alkyloxy, etc.; R2a to R2d independently represent a hydrogen atom, etc.; ring B represents a 4- to 8-membered non-aromatic carbon ring, etc.; R3s independently represent a halogen, etc.; r is an integer of 0-4; and R4 represents an optionally substituted aromatic heterocyclic group, etc.) or a pharmaceutically acceptable salt thereof.

More Like This:
JP7319977tubulin inhibitor
JP2009143904BENZAMIDE DERIVATIVE
WO/2016/083816N-((HETEROARYLMETHYL)-HETEROARYL-CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS
Inventors:
TOBINAGA HIROYUKI (JP)
MASUDA KOJI (JP)
Application Number:
PCT/JP2019/002396
Publication Date:
August 01, 2019
Filing Date:
January 25, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHIONOGI & CO (JP)
International Classes:
C07D471/04; A61K31/55; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/30; A61P43/00; C07D513/04
Domestic Patent References:
WO2018021447A12018-02-01
WO1998050364A11998-11-12
WO2000021951A12000-04-20
WO1998051671A11998-11-19
WO1999059974A11999-11-25
WO1996002249A11996-02-01
WO1997038998A11997-10-23
WO1998006699A11998-02-19
WO1998049145A11998-11-05
WO1998050363A11998-11-12
WO1998050364A11998-11-12
WO1998051671A11998-11-19
WO1999059974A11999-11-25
WO1999064412A11999-12-16
WO2000021950A12000-04-20
WO2000021951A12000-04-20
WO2000024717A22000-05-04
WO2002040471A22002-05-23
WO2004069830A12004-08-19
WO2006050976A12006-05-18
WO2011109441A12011-09-09
WO2009011904A12009-01-22
WO2017021920A12017-02-09
WO2018021447A12018-02-01
WO2006001752A12006-01-05
Foreign References:
US5294621A1994-03-15
Other References:
DATABASE REGISTRY 26 February 2018 (2018-02-26), retrieved from STN Database accession no. RN2180090-16-6
DATABASE REGISTRY 26 February 2018 (2018-02-26), retrieved from STN Database accession no. RN2180085-11-2
DRUG DISCOVERY TODAY, vol. 10, no. 13, 2005, pages 917 - 925
PHARMACOLOGY & THERAPEUTICS, vol. 90, 2001, pages 231 - 259
JOURNAL OF CLINICAL PSYCHIATRY, vol. 71, no. 9, 2010, pages 1131 - 1137
NEUROPSYCHOPHARMACOLOGY, vol. 37, 2012, pages 770 - 786
PSYCHOPHARMACOLOGY, vol. 196, no. 1, 2008, pages 157 - 165
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, vol. 29, no. 6, 2009, pages 571 - 575
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 344, 2013, pages 501 - 510
CHEMBIOCHEM, vol. 5, 2004, pages 508 - 518
JOURNAL OF MEDICINAL CHEMISTRY, vol. 58, 2015, pages 5287 - 5307
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 22, no. 14, 2012, pages 4540 - 4545
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 10, 2000, pages 2553 - 2555
JOURNAL OF MEDICINAL CHEMISTRY, vol. 46, 2003, pages 4952 - 4964
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 7, no. 18, 1997, pages 2403 - 2408
"Isotopes in the Physical and Biomedical Sciences", vol. 1, 1987, LABELED COMPOUNDS (PART A
"Design of Prodrugs", 1985, ELSEVIER
THEODORA W GREENE: "Protective Groups in Organic Synthesis", JOHN WILEY & SONS
See also references of EP 3744721A4
Attorney, Agent or Firm:
SUGITA Ken-ichi et al. (JP)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: STRESS STATE DETECTION METHOD AND STRESS DETECTION DEVICE

Next Patent: CYCLIC COMPOUND HAVING DOPAMINE D3 RECEPTOR ANTAGONISM